We are looking for child to join a Crohn’s disease (CD) clinical research to help us discover more about treating moderately to severely active IBD. If you are looking for a potential new treatment option for moderately to severely active IBD or Inflammatory bowel disease (including associated symptoms such as diarrhea with pus, persistent diarrhea, constant need to poop, weight loss and/or liver disease), consider one of our GI clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your child may be eligible to take part.

Your child may be eligible to take part in the GI clinical trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child is eligible.

Is your child currently experiencing Crohn’s disease flare-ups? Local Crohn’s disease (CD) trial is testing a potential new medication to see if it may reduce painful joints, iron deficiency, rectal pain, chronic fatigue, and/or anemia associated with Crohn’s disease.
If you’re concerned about how Crohn’s disease affects your child’s life, find out more about the Crohn’s disease (CD) trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrolling for a limited time.

We are looking for 2–17 years of age to join a CD medical research study to help us discover more about treating IBD. If you are looking for a potential new treatment option for IBD or moderately to severely active ulcerative colitis (including associated symptoms such as urgency to defecate, weight loss, constant need to poop, chronic fatigue and/or canker sores), consider one of our GI medical research studies. All eligible participants will receive no-cost study-related care and study medication. Your 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the GI medical research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrolling for a limited time.

Is your child currently experiencing ulcerative colitis flare-ups? Local Crohn’s disease research is testing a potential new medication to see if it may reduce abdominal cramps, failure to thrive, bloody stool, malnutrition, and/or canker sores associated with ulcerative colitis.
If you’re concerned about how ulcerative colitis affects your child’s life, find out more about the Crohn’s disease research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Act now.

We are looking for children aged 2 to 17 years to join a clinical research to help us discover more about treating CD. If you are looking for a potential new treatment option for CD or moderate to severe CD (including associated symptoms such as chronic diarrhea, abdominal cramps, rectal pain, malnutrition and/or eye pain), consider one of our IBD studies. All eligible participants will receive no-cost study-related care and study medication. Your children aged 2 to 17 years may be eligible to take part.

Your child may be eligible to take part in the IBD studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Act now.

Is your child currently experiencing UC flare-ups? Local Crohn’s disease research is testing a potential new medication to see if it may reduce tiredness, stomach pain, constant need to poop, malnutrition, and/or liver disease associated with UC.
If you’re concerned about how UC affects your child’s life, find out more about the Crohn’s disease research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child qualifies.

We are looking for children 2 to 17 years of age to join a Crohn’s disease trial to help us discover more about treating moderate to severe ulcerative colitis. If you are looking for a potential new treatment option for moderate to severe ulcerative colitis or Crohn’s (including associated symptoms such as chronic diarrhea, persistent diarrhea, diarrhea, chronic fatigue and/or liver disease), consider one of our CD and UC studies. All eligible participants will receive no-cost study-related care and study medication. Your children 2 to 17 years of age may be eligible to take part.

Your child may be eligible to take part in the CD and UC studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child qualifies.

Is your child currently experiencing moderate to severe IBD flare-ups? Local Crohn’s disease (CD) clinical trial is testing a potential new medication to see if it may reduce fatigue, blood in the stool, constant need to poop, weight loss, and/or joint pain associated with moderate to severe IBD.
If you’re concerned about how moderate to severe IBD affects your child’s life, find out more about the Crohn’s disease (CD) clinical trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrollment is limited, so please respond now.

We are looking for young people 2–17 years of age to join a Crohn’s disease (CD) clinical research to help us discover more about treating IBD. If you are looking for a potential new treatment option for IBD or moderate to severe Crohn’s disease (including associated symptoms such as diarrhea with pus, persistent diarrhea, abdominal pain, frequent fevers and/or eye pain), consider one of our IBD clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your child or teen 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the IBD clinical trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrollment is limited, so please respond now.

Is your child currently experiencing Crohn’s and ulcerative colitis flare-ups? Local Crohn’s disease medical research study is testing a potential new medication to see if it may reduce urgency to defecate, unexplained weight loss, cramps, chronic fatigue, and/or canker sores associated with Crohn’s and ulcerative colitis.
If you’re concerned about how Crohn’s and ulcerative colitis affects your child’s life, find out more about the Crohn’s disease medical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child qualifies.